$IMNN
Imunon, Inc. Stock $imnn

$imnn Overview Financials Valuation SEC Filings Company Website

2017 Q4 Form 10-K Financial Statement

#000143774918005539 Filed on March 27, 2018

Income Statement

Concept	2017 Q4	2017	2016 Q4
Revenue	$130.0K	$500.0K	$130.0K
YoY Change	0.0%	0.0%	0.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$1.600M	$5.890M	$1.640M
YoY Change	-2.44%	-9.8%	19.71%
% of Gross Profit
Research & Development	$3.210M	$13.08M	$3.620M
YoY Change	-11.33%	-10.56%	-2.16%
% of Gross Profit
Depreciation & Amortization	$40.00K	$553.0K	$660.0K
YoY Change	-93.94%	-45.93%	560.0%
% of Gross Profit
Operating Expenses	$4.810M	$18.97M	$5.260M
YoY Change	-8.56%	-10.31%	3.75%
Operating Profit		-$18.47M
YoY Change		-10.56%
Interest Expense	$20.00K	-$70.00K	-$110.0K
YoY Change	-118.18%	-89.86%	-57.69%
% of Operating Profit
Other Income/Expense, Net	-$20.00K	-$1.934M	$1.290M
YoY Change	-101.55%	37.74%	-516.13%
Pretax Income	-$4.680M	-$20.40M	-$5.400M
YoY Change	-13.33%	-7.48%	-2.0%
Income Tax
% Of Pretax Income
Net Earnings	-$4.680M	-$20.40M	-$5.400M
YoY Change	-13.33%	-7.49%	-2.0%
Net Earnings / Revenue	-3600.0%	-4080.44%	-4153.85%
Basic Earnings Per Share
Diluted Earnings Per Share	-$312.2K	-$2.674M	-$2.660M
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept	2017 Q4	2017	2016 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$24.17M	$24.17M	$4.300M
YoY Change	462.05%	462.09%	-78.57%
Cash & Equivalents	$11.44M	$11.44M	$2.624M
Short-Term Investments	$12.72M	$12.72M	$1.680M
Other Short-Term Assets		$90.00K	$115.2K
YoY Change		-57.14%	-39.36%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$24.31M	$24.31M	$4.513M
YoY Change	438.75%	439.02%	-77.75%
LONG-TERM ASSETS
Property, Plant & Equipment	$175.8K	$180.0K	$462.8K
YoY Change	-62.02%	-60.87%	-45.86%
Goodwill	$1.976M		$1.976M
YoY Change	0.0%		0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$8.761K	$10.00K	$8.761K
YoY Change	0.0%	-90.91%	-92.04%
Total Long-Term Assets	$23.03M	$23.20M	$25.87M
YoY Change	-11.0%	-11.92%	-7.23%
TOTAL ASSETS
Total Short-Term Assets	$24.31M	$24.31M	$4.513M
Total Long-Term Assets	$23.03M	$23.20M	$25.87M
Total Assets	$47.51M	$47.51M	$30.85M
YoY Change	54.02%	54.0%	-37.08%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.417M	$3.420M	$2.879M
YoY Change	18.68%	18.75%	1.72%
Accrued Expenses	$2.283M	$2.280M	$2.484M
YoY Change	-8.09%	-8.06%	29.38%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due			$2.560M
YoY Change			-37.1%
Total Short-Term Liabilities	$6.200M	$6.200M	$8.423M
YoY Change	-26.4%	-26.37%	-9.66%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change			-100.0%
Other Long-Term Liabilities	$71.71K	$14.61M	$12.35K
YoY Change	480.55%	-6.94%	-74.05%
Total Long-Term Liabilities	$71.71K	$14.61M	$12.35K
YoY Change	480.55%	-6.94%	-74.05%
TOTAL LIABILITIES
Total Short-Term Liabilities	$6.200M	$6.200M	$8.423M
Total Long-Term Liabilities	$71.71K	$14.61M	$12.35K
Total Liabilities	$20.81M	$20.81M	$24.12M
YoY Change	-13.74%	-13.72%	-15.78%
SHAREHOLDERS EQUITY
Retained Earnings	-$261.8M		-$241.4M
YoY Change	8.45%		10.66%
Common Stock	$288.6M		$248.2M
YoY Change	16.27%		3.45%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$85.19K		$85.19K
YoY Change	0.0%		-93.84%
Treasury Stock Shares	$334.00		$334.00
Shareholders Equity	$26.70M	$26.70M	$6.726M
YoY Change
Total Liabilities & Shareholders Equity	$47.51M	$47.51M	$30.85M
YoY Change	54.02%	54.0%	-37.08%

Cashflow Statement

Concept	2017 Q4	2017	2016 Q4
OPERATING ACTIVITIES
Net Income	-$4.680M	-$20.40M	-$5.400M
YoY Change	-13.33%	-7.49%	-2.0%
Depreciation, Depletion And Amortization	$40.00K	$553.0K	$660.0K
YoY Change	-93.94%	-45.93%	560.0%
Cash From Operating Activities	-$4.210M	-$16.64M	-$4.660M
YoY Change	-9.66%	-9.45%	19.49%
INVESTING ACTIVITIES
Capital Expenditures	-$20.00K	$38.63K	-$10.00K
YoY Change	100.0%	-38.2%
Acquisitions
YoY Change
Other Investing Activities	-$12.73M	-$10.95M	$2.840M
YoY Change	-548.24%	-220.07%	-52.43%
Cash From Investing Activities	-$12.75M	-$10.99M	$2.820M
YoY Change	-552.13%	-221.32%	-52.76%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	25.71M	36.45M	280.0K
YoY Change	9082.14%	1261.44%	-173.68%
NET CHANGE
Cash From Operating Activities	-4.210M	-16.64M	-4.660M
Cash From Investing Activities	-12.75M	-10.99M	2.820M
Cash From Financing Activities	25.71M	36.45M	280.0K
Net Change In Cash	8.750M	8.820M	-1.560M
YoY Change	-660.9%	-232.81%	-192.31%
FREE CASH FLOW
Cash From Operating Activities	-$4.210M	-$16.64M	-$4.660M
Capital Expenditures	-$20.00K	$38.63K	-$10.00K
Free Cash Flow	-$4.190M	-$16.68M	-$4.650M
YoY Change	-9.89%	-9.55%	19.23%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	135.95
CY2017Q4	clsn	Accrued Interest On Notes Payable AccruedInterestOnNotesPayable
CY2016Q4	clsn	Accrued Interest On Notes Payable AccruedInterestOnNotesPayable	22241
CY2016Q2	clsn	Aggregate Of Common And Preferred Stock Shares Authorized AggregateOfCommonAndPreferredStockSharesAuthorized	112600000
CY2017	clsn	Aggregate Offering Price Additions AggregateOfferingPriceAdditions	13500000
CY2017	clsn	Amount Of Time After Effective Date Of License Agreement For Registration Rights To Take Place AmountOfTimeAfterEffectiveDateOfLicenseAgreementForRegistrationRightsToTakePlace	P1Y
CY2017Q4	clsn	Class Of Warrant Or Right Aggregate Intrinsic Value Of Outstanding Warrants ClassOfWarrantOrRightAggregateIntrinsicValueOfOutstandingWarrants	37143
CY2016	clsn	Class Of Warrant Or Right Exercised During Period Exercise Price ClassOfWarrantOrRightExercisedDuringPeriodExercisePrice	0.14
CY2017	clsn	Class Of Warrant Or Right Exercised During Period Exercise Price ClassOfWarrantOrRightExercisedDuringPeriodExercisePrice	2.89
CY2016	clsn	Class Of Warrant Or Right Expired During Period ClassOfWarrantOrRightExpiredDuringPeriod	62795
CY2017	clsn	Class Of Warrant Or Right Expired During Period ClassOfWarrantOrRightExpiredDuringPeriod	44037
CY2016	clsn	Class Of Warrant Or Right Expired During Period Exercise Price ClassOfWarrantOrRightExpiredDuringPeriodExercisePrice	209.23
CY2017	clsn	Class Of Warrant Or Right Expired During Period Exercise Price ClassOfWarrantOrRightExpiredDuringPeriodExercisePrice	174.58
CY2016	clsn	Class Of Warrant Or Right Issued During Period ClassOfWarrantOrRightIssuedDuringPeriod	1147595
CY2017	clsn	Class Of Warrant Or Right Issued During Period ClassOfWarrantOrRightIssuedDuringPeriod	9231628
CY2016	clsn	Class Of Warrant Or Right Issued During Period Exercise Price ClassOfWarrantOrRightIssuedDuringPeriodExercisePrice	2.03
CY2017	clsn	Class Of Warrant Or Right Issued During Period Exercise Price ClassOfWarrantOrRightIssuedDuringPeriodExercisePrice	3.46
CY2017	clsn	Class Of Warrant Or Right Weighted Average Remaining Contractual Terms ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms	P3Y182D
CY2016	clsn	Class Of Warrants Or Right Exercised During Period ClassOfWarrantsOrRightExercisedDuringPeriod	17857
CY2017	clsn	Class Of Warrants Or Right Exercised During Period ClassOfWarrantsOrRightExercisedDuringPeriod	7617147
CY2017	clsn	Deemed Dividend Related To Warrant Modification DeemedDividendRelatedToWarrantModification	345685
CY2016	clsn	Deemed Dividend Related To Warrant Modification DeemedDividendRelatedToWarrantModification
CY2017	clsn	Deferred Finance Charges DeferredFinanceCharges	35370
CY2016	clsn	Deferred Finance Charges DeferredFinanceCharges	236666
CY2013Q1	clsn	Deferred Revenue Amortization Period DeferredRevenueAmortizationPeriod	P10Y
CY2017	clsn	Defined Contribution Plan Employer Discretionary Contribution Percent DefinedContributionPlanEmployerDiscretionaryContributionPercent	0.06
CY2015Q4	clsn	Earnout Milestone Liability EarnoutMilestoneLiability	13921412
CY2016Q4	clsn	Earnout Milestone Liability EarnoutMilestoneLiability	13188226
CY2017Q4	clsn	Earnout Milestone Liability EarnoutMilestoneLiability	12538525
	clsn	Operating Loss Carry Forwards Limitation On Use OperatingLossCarryForwardsLimitationOnUse	1500000
	clsn	Operating Loss Carry Forwards Limitation On Use OperatingLossCarryForwardsLimitationOnUse	1600000
	clsn	Operating Loss Carry Forwards Limitation On Use OperatingLossCarryForwardsLimitationOnUse	300000
CY2016	clsn	Number Of Warrants Issued NumberOfWarrantsIssued	1147595
CY2011Q3	clsn	Operating Loss Carry Forwards Limitation On Use OperatingLossCarryForwardsLimitationOnUse	4200000
	clsn	Operating Loss Carry Forwards Limitation On Use OperatingLossCarryForwardsLimitationOnUse	1400000
	clsn	Operating Loss Carry Forwards Limitation On Use OperatingLossCarryForwardsLimitationOnUse	300000
	clsn	Operating Loss Carry Forwards Limitation On Use OperatingLossCarryForwardsLimitationOnUse	800000
CY2017Q3	clsn	Gain Loss From Change In Fair Value Of Earn Out Milestone Liability GainLossFromChangeInFairValueOfEarnOutMilestoneLiability	1200000
CY2016	clsn	Gain Loss From Change In Fair Value Of Earn Out Milestone Liability GainLossFromChangeInFairValueOfEarnOutMilestoneLiability	733186
CY2017	clsn	Gain Loss From Change In Fair Value Of Earn Out Milestone Liability GainLossFromChangeInFairValueOfEarnOutMilestoneLiability	649701
CY2017	clsn	Gain Loss From Valuation Of Earnout Milestone Liability GainLossFromValuationOfEarnoutMilestoneLiability	649701
CY2016	clsn	Gain Loss From Valuation Of Earnout Milestone Liability GainLossFromValuationOfEarnoutMilestoneLiability	733186
CY2017Q4	clsn	Minimum Age For Employee Benefit Plan MinimumAgeForEmployeeBenefitPlan	21
CY2017	clsn	Number Of Days Before Issuance Factoring Into Average Closing Price NumberOfDaysBeforeIssuanceFactoringIntoAverageClosingPrice	P20D
CY2017	clsn	Number Of Shares Of Common Stock Issuable Upon Exercise Of Warrants And Equity Awards NumberOfSharesOfCommonStockIssuableUponExerciseOfWarrantsAndEquityAwards	3761844
CY2016	clsn	Number Of Shares Of Common Stock Issuable Upon Exercise Of Warrants And Equity Awards NumberOfSharesOfCommonStockIssuableUponExerciseOfWarrantsAndEquityAwards	1702272
CY2017Q4	clsn	Number Of Trademark Protection Application Pending For Thermo Dox NumberOfTrademarkProtectionApplicationPendingForThermoDox	14
CY2017	clsn	Number Of Warrants Issued NumberOfWarrantsIssued	9231628
CY2017	clsn	Refund Of Deposit For Letter Of Credit RefundOfDepositForLetterOfCredit	100000
CY2016	clsn	Refund Of Deposit For Letter Of Credit RefundOfDepositForLetterOfCredit
CY2015Q3	clsn	Shelf Registration Statement Amount ShelfRegistrationStatementAmount	75000000
CY2017	clsn	Stock Issued During Period Value Reverse Stock Splits StockIssuedDuringPeriodValueReverseStockSplits
CY2017	clsn	Treasury Stock Contributed To401 K Plan TreasuryStockContributedTo401KPlan
CY2016	clsn	Treasury Stock Contributed To401 K Plan TreasuryStockContributedTo401KPlan	101491
CY2017Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	264668
CY2016Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	259550
CY2017Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3416863
CY2016Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2878978
CY2017	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments
CY2016	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-3808
CY2017Q4	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	54440
CY2016Q4	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	4008
CY2017Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2282827
CY2016Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2483756
CY2017Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2838716
CY2016Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2513022
CY2017Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-10164
CY2016Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax
CY2017Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	288408976
CY2016Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	248168421
CY2016	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1332838
CY2017	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1105245
CY2017	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	345685
CY2017	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets
CY2016	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	5625
CY2016	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1570300
CY2017Q4	us-gaap	Assets Assets	47514433
CY2016Q4	us-gaap	Assets Assets	30849691
CY2017Q4	us-gaap	Assets Current AssetsCurrent	24311701
CY2016Q4	us-gaap	Assets Current AssetsCurrent	4512578
CY2017Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	23026961
CY2016Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	25874277
CY2017Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	12734184
CY2016Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	1680000
CY2017Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	12724020
CY2016Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainLossBeforeTax	0
CY2017Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss	10164
CY2017Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	12724020
CY2016Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	1680000
CY2017	us-gaap	Available For Sale Securities Gross Realized Gain Loss Net AvailableForSaleSecuritiesGrossRealizedGainLossNet
CY2016	us-gaap	Available For Sale Securities Gross Realized Gain Loss Net AvailableForSaleSecuritiesGrossRealizedGainLossNet	-532
CY2017Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	12538525
CY2016Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	13188226
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2624162
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9265144
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	11444055
CY2017	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	8819893
CY2016	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-6640982
CY2017Q4	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	24200000
CY2017Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	2.70
CY2017Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.65
CY2015Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	5888
CY2016Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	9.39
CY2017Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	5.29
CY2017Q2	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	790410
CY2017Q2	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	506627
CY2017Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	33500000
CY2017Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	2400000
CY2015Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	421015
CY2016Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1487958
CY2017Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	3058402
CY2017Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2016Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2017Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2016Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000
CY2016Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	112500000
CY2017Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	112500000
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	112500000
CY2003Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	253691
CY2017Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	17277299
CY2016Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2230452
CY2017Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	56982418
CY2017Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4070172
CY2017Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	17276965
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2230118
CY2003Q1	us-gaap	Common Stock Value CommonStockValue	2200000
CY2017Q4	us-gaap	Common Stock Value CommonStockValue	172772
CY2016Q4	us-gaap	Common Stock Value CommonStockValue	22305
CY2017	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-20412340
CY2016	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-22049868
CY2017Q4	us-gaap	Contractual Obligation ContractualObligation	665373
CY2016Q4	us-gaap	Contractual Obligation ContractualObligation	1115193
CY2013Q1	us-gaap	Deferred Revenue DeferredRevenue	5000000
CY2017Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	500000
CY2016Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	500000
CY2017Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	2000000
CY2016Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	2500000
CY2017Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	64631000
CY2016Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	84049000
CY2017Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet
CY2016Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet
CY2017Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	62216000
CY2016Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	81335000
CY2017Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Subject To Expiration DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration	225422000
CY2017Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation	2415000
CY2016Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation	2714000
CY2017Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	64631000
CY2016Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	84049000
CY2017	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	77352
CY2016	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	82391
CY2017	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	172497
CY2017	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Percent DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent	0.03
CY2017	us-gaap	Depreciation Depreciation	326000
CY2016	us-gaap	Depreciation Depreciation	455000
CY2017	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	553010
CY2016	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1022829
CY2017	us-gaap	Dividends Dividends	345685
CY2017	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-2.72
CY2016	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-11.89
CY2017	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations
CY2016	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations
CY2017	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.34
CY2016	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.34
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.406
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.395
CY2017	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.066
CY2016	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.055
CY2017Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1258265
CY2016Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1066751
CY2017	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P10Y
CY2017Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	7500
CY2016Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	7500
CY2017Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	795608
CY2016Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1022924
CY2016Q4	us-gaap	Finite Lived Patents Gross FiniteLivedPatentsGross	75000
CY2017	us-gaap	Gain Loss On Sale Of Securities Net GainLossOnSaleOfSecuritiesNet
CY2016	us-gaap	Gain Loss On Sale Of Securities Net GainLossOnSaleOfSecuritiesNet	-532
CY2017	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5889722
CY2016	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6526752
CY2017Q4	us-gaap	Goodwill Goodwill	1976101
CY2016Q4	us-gaap	Goodwill Goodwill	1976101
CY2017Q4	us-gaap	Grants Receivable Current GrantsReceivableCurrent	89186
CY2016Q4	us-gaap	Grants Receivable Current GrantsReceivableCurrent	89186
CY2017	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	2520000
CY2016	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	1444023
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	47514433
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	30849691
CY2017	us-gaap	Income Taxes Paid IncomeTaxesPaid
CY2016	us-gaap	Income Taxes Paid IncomeTaxesPaid
CY2017	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	537885
CY2016	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	48751
CY2017	us-gaap	Increase Decrease In Accrued Investment Income Receivable IncreaseDecreaseInAccruedInvestmentIncomeReceivable	50432
CY2016	us-gaap	Increase Decrease In Accrued Investment Income Receivable IncreaseDecreaseInAccruedInvestmentIncomeReceivable	-22721
CY2017	us-gaap	Increase Decrease In Deferred Liabilities IncreaseDecreaseInDeferredLiabilities	59358
CY2016	us-gaap	Increase Decrease In Deferred Liabilities IncreaseDecreaseInDeferredLiabilities	-35245
CY2017	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-500000
CY2016	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-500000
CY2017	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-200929
CY2016	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	563987
CY2017	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-115222
CY2016	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	14855
CY2017	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	649701
CY2016	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	733186
CY2017Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	20246491
CY2016Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	22766491
CY2017	us-gaap	Interest And Debt Expense InterestAndDebtExpense	91756
CY2016	us-gaap	Interest And Debt Expense InterestAndDebtExpense	722993
CY2017	us-gaap	Interest Paid Net InterestPaidNet	56386
CY2016	us-gaap	Interest Paid Net InterestPaidNet	486327
CY2017	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	26041
CY2016	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	31262
CY2017	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	26041
CY2016	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	26922
CY2017	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	235072
CY2016	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims
CY2017Q4	us-gaap	Liabilities Liabilities	20809925
CY2016Q4	us-gaap	Liabilities Liabilities	24123865
CY2017	us-gaap	Net Income Loss NetIncomeLoss	-20402176
CY2016	us-gaap	Net Income Loss NetIncomeLoss	-22053726
CY2017	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-20747861
CY2016	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-22053726
CY2017	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1933744
CY2016	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1403906
CY2017Q4	us-gaap	Notes Payable Current NotesPayableCurrent
CY2016Q4	us-gaap	Notes Payable Current NotesPayableCurrent	2560553
CY2017	us-gaap	Operating Expenses OperatingExpenses	18968432
CY2016	us-gaap	Operating Expenses OperatingExpenses	21149820
CY2017	us-gaap	Operating Income Loss OperatingIncomeLoss	-18468432
CY2017Q4	us-gaap	Liabilities Current LiabilitiesCurrent	6199690
CY2016Q4	us-gaap	Liabilities Current LiabilitiesCurrent	8423287
CY2017	us-gaap	Licenses Revenue LicensesRevenue	500000
CY2016	us-gaap	Licenses Revenue LicensesRevenue	500000
CY2017	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	36454782
CY2016	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2677669
CY2017	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-10992813
CY2016	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	9060713
CY2017	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-16642076
CY2016	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-18379364
CY2016	us-gaap	Operating Income Loss OperatingIncomeLoss	-20649820
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	2212652000
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	452093000
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	379823000
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	457995000
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	454213000
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	450430000
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	18098000
CY2017Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	89000000
CY2011Q3	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	90000000
CY2013Q1	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	34000000
CY2013Q2	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	4000000
CY2015Q2	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	40000000
CY2017Q1	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	35000000
CY2017Q2	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	7000000
CY2017Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	5000000
CY2017Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	94521
CY2016Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	20021
CY2017Q4	us-gaap	Other Assets Current OtherAssetsCurrent
CY2016Q4	us-gaap	Other Assets Current OtherAssetsCurrent	115222
CY2017Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	8761
CY2016Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	8761
CY2017	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-10164
CY2016	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	3858
CY2017	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
CY2016	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	-532
CY2017	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-10164
CY2016	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	3326
CY2017Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	71710
CY2016Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	12352
CY2017	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2270
CY2016	us-gaap	Proceeds From Issuance Of Redeemable Convertible Preferred Stock ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock	6775016
CY2017	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	1680000
CY2016	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	13635000
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	2100000
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	800000
CY2017	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	21140304
CY2016	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	3002
CY2017	us-gaap	Payments For Rent PaymentsForRent	502716
CY2016	us-gaap	Payments For Rent PaymentsForRent	575516
CY2017	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	12734184
CY2016	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	4511784
CY2017	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	38629
CY2016	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	62503
CY2016Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000
CY2017Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000
CY2016Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000
CY2017Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2016Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2017Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2016Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2017Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2016Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2017	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-style: italic;">Reclassifications</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-right:7.7pt;margin-top:0pt;text-align:justify;">Certain reclassifications have been made to prior year financial statements to conform to classifications used in the current year. These classifications had <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> impact on net loss, stockholders<div style="display: inline; font-family:'Times New Roman', Times, serif;font-size:10pt;">’ equity or cash flows as previously reported.  See Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div> regarding the reverse stock split which occurred on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May 26, 2017. </div></div></div></div></div></div></div></div></div></div></div></div></div>
CY2017	us-gaap	Proceeds From Issuance Of Redeemable Convertible Preferred Stock ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock	17910401
CY2016	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	2500
CY2017Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3014487
CY2016Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2975858
CY2017Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	175771
CY2016Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	462836
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	164.12
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	60449
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	535964
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2400000
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	200000
CY2017	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	2595923
CY2016	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	4099847
CY2017	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	13078710
CY2016	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	14623068
CY2017Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-261781888
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-241379712
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	154581
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	211213
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	703442
CY2016Q4	us-gaap	Short Term Investments ShortTermInvestments	1680000
CY2016	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	2500
CY2017Q4	us-gaap	Security Deposit SecurityDeposit
CY2016Q4	us-gaap	Security Deposit SecurityDeposit	100000
CY2017	us-gaap	Share Based Compensation ShareBasedCompensation	1105245
CY2016	us-gaap	Share Based Compensation ShareBasedCompensation	1511023
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P8Y328D
CY2006Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	21164
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	405075
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	14.97
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	3817
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	43735
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	80.44
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	61.59
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	10.34
CY2016	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	18.08
CY2017	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	2.69
CY2017Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	405075
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P8Y219D
CY2017Q4	us-gaap	Short Term Investments ShortTermInvestments	12724020
CY2017	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	21140304
CY2017	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	235072
CY2016	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	6775016
CY2017	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	17910401
CY2016	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	178185
CY2017	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross
CY2016	us-gaap	Stock Issued During Period Value Treasury Stock Reissued StockIssuedDuringPeriodValueTreasuryStockReissued	101491
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	26704508
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	6725826
CY2015Q4	us-gaap	Stockholders Equity StockholdersEquity	20385664
CY2017Q4	us-gaap	Stockholders Equity Before Treasury Stock StockholdersEquityBeforeTreasuryStock	26789696
CY2016Q4	us-gaap	Stockholders Equity Before Treasury Stock StockholdersEquityBeforeTreasuryStock	6811014
CY2017Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	334
CY2016Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	334
CY2017Q4	us-gaap	Treasury Stock Value TreasuryStockValue	85188
CY2016Q4	us-gaap	Treasury Stock Value TreasuryStockValue	85188
CY2017	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	7627210
CY2016	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	1854054
CY2016	us-gaap	Weighted Average Number Of Shares Contingently Issuable WeightedAverageNumberOfSharesContingentlyIssuable	132142

Files In Submission

Name	View Source	Status
0001437749-18-005539-index-headers.html	Edgar Link	pending
0001437749-18-005539-index.html	Edgar Link	pending
0001437749-18-005539.txt	Edgar Link	pending
R42.htm	Edgar Link	pending
0001437749-18-005539-xbrl.zip	Edgar Link	pending
clsn-20171231.xml	Edgar Link	completed
clsn-20171231.xsd	Edgar Link	pending
clsn-20171231_cal.xml	Edgar Link	unprocessable
clsn-20171231_def.xml	Edgar Link	unprocessable
clsn-20171231_lab.xml	Edgar Link	unprocessable
clsn-20171231_pre.xml	Edgar Link	unprocessable
clsn20171231_10k.htm	Edgar Link	pending
ex_108292.htm	Edgar Link	pending
ex_108293.htm	Edgar Link	pending
ex_108294.htm	Edgar Link	pending
ex_108295.htm	Edgar Link	pending
ex_108296.htm	Edgar Link	pending
ex_108297.htm	Edgar Link	pending
ex_108298.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$IMNN
Imunon, Inc. Stock $imnn

2017 Q4 Form 10-K Financial Statement

#000143774918005539 Filed on March 27, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$IMNN Imunon, Inc. Stock $imnn

2017 Q4 Form 10-K Financial Statement

#000143774918005539 Filed on March 27, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$IMNN
Imunon, Inc. Stock $imnn